Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Recent progress in deciphering the mechanisms underlying the concepts of tumor immunosurveillance and immunoevasion has opened new opportunities for the development of effective anti-tumor therapies. Transplant physicians and immunologists have much to learn from those direct clinical translations of basic science. The 2016 Beaune Seminar in Transplant research brought together researchers from both fields to explore and discuss significant advances in cancer biology, immunotherapies and their potential impacts for the management of cancer in transplant recipients.

Original publication




Journal article



Publication Date



1Department of Nephrology, Dialysis and Transplantation, Nord University Hospital, Saint-Etienne, France. 2GIMAP - EA3064, COMUE University of Lyon, Saint-Etienne, France. 3Department of Transplantation, Nephrology and Clinical Immunology, Edouard Herriot Hospital, Hospices Civiles de Lyon, Lyon, France. 4Department of Nephrology and Transplantation, University Hospital, Dijon, France. 5Transplantation Research Immunology Group, Nuffield Department of Surgical Sciences, University of Oxford, John Radcliffe Hospital, Oxford, UK.